期刊文献+

三个多发性内分泌腺瘤2A型家系的临床诊治及RET原癌基因突变检测 被引量:3

The clinical diagnosis, treatment and RET proto-oncogene screening in three multiple endocrineneoplasia type 2A pedigrees
原文传递
导出
摘要 目的 探讨3个多发性内分泌腺瘤2A型(MEN2A)家系的诊治及RET基因检测的临床意义.方法 分析1990年4月至2011年12月诊治的3个家系10例MEN2A患者的临床资料.男4例,女6例.5例以颈部占位就诊:3例接受了不规范的甲状腺全切除术,2例接受双侧甲状腺全切+双侧颈部改良淋巴结清扫;5例无甲状腺肿瘤症状的RET基因突变携带者行双侧甲状腺全切+至少双侧颈部Ⅵ区淋巴结清扫.6例伴发肾上腺嗜铬细胞瘤(PHEO):5例行双侧PHEO一期切除,1例行单侧PHEO切除.3个家系共23例成员接受外周血RET基因检测.结果 病理均明确诊断双侧甲状腺髓样癌(10/10).有、无症状的甲状腺髓样癌(MTC)患者间的首次平均诊断年龄[39.0(31 ~64)岁比18.2(5.5 ~36)岁]、肿瘤最大直径[2.8(1.2~5.6) cm比0.7(0.2 ~ 1.3) cm]、淋巴结阳性转移率[100% (5/5)比20% (1/5)],差异均有统计学意义(均P<0.05).MTC随访7~ 66个月,术后降钙素有症状组均升高(5/5),无症状组仅见1例升高(P<0.05).6例PHEO(60%)的平均诊断年龄42.0岁,5例为双侧多发,1例为单侧单发;3例双侧PHEO术后需终生口服激素替代.PHEO随访19 ~ 104个月,6例均无复发或转移.基因检测均为RET基因p.C634Y突变(10/23),1个家系为RET基因p.C634Y新发突变(de novo).结论 基于RET基因和血清降钙素检测及早进行规范手术可有效治愈MEN2A-MTC;对伴有双侧PHEO者,应优先选择保留肾上腺皮质功能的腹腔镜下双侧PHEO一期切除术. Objective To discuss clinical characteristics,treatment and clinical significance for RET screening in 3 multiple endocrine neoplasia type 2A (MEN2A) pedigrees.Methods The clinical data of 10 MEN2A patients from 3 unrelated MEN2A pedigrees from April 1990 to December 2011 were analyzed.There were 4 males and 6 females.5 patients with symptomatic palpable neck masses underwent bilateral total thyroidectomy + bilateral neck lymph node dissection.Other 5 RET screening detected asymptomatic thyroid cancer patients underwent bilateral total thyroidectomy + bilateral level Ⅵ lymph node dissection.6 adrenal pheochromocytoma (PHEO) patients received bilateral adrenalectomy (5 cases) or unilateral adrenalectomy (1 case).23 members from 3 families agreed to participate in biochemical testing,image examinations and RET screening.Results Histopathology revealed bilateral medullary thyroid carcinoma (MTC) in all 10 patients (100%).The two groups (symptomatic and asymptomatic) have significantly differences from the first diagnostic age [39.0 (31-64) years vs.18.2 (5.5-36) years],tumor maximum diameter [2.8 (1.2-5.6) cm vs.0.7 (0.2-1.3) cm] and positive lymph node metastatic ratio [100% (5/5) vs.20% (1/5)] (P 〈 0.05).These MTC cases were followed-up for 7-66 months,postoperative calcitonin still positive in all 5 preoperatively symptomatic patients,while in only 1 preoperatively asymptomatic patient (P 〈 0.05).PHEO was bilateral,multiple in 5 patients and unilateral multiple in 1 patient.Postoperatively 3 patients need lifelong steroid substitution.19-104 months follow-up found no recurrence or metastasis.RET screening showed a missense mutations of TGC to TAC (p.C634Y)at codon 634 on exon 11 in all 10 patients,and a patient was diagnosed as having de novo MEN2A.Conclusions Based on RET screening and serum calcitonin monitoring,early and radical surgery can cure MEN2A related MTC; One stage bilateral laparoscopic cortical-sparing adrenalectomy is recomme
出处 《中华普通外科杂志》 CSCD 北大核心 2013年第10期782-786,共5页 Chinese Journal of General Surgery
基金 南京军区医学科技创新课题基金重点资助项目(092038、102036)
关键词 多发性内分泌瘤病2A型 甲状腺肿瘤 嗜铬细胞瘤 原癌基因 点突变 Multiple endocrine neoplasia type 2a Thyroid neoplasms Pheochromoeytoma Proto-oncogene Point mutation
  • 相关文献

参考文献10

  • 1American Thyroid Association Guidelines Task Force.Medullary thyroid cancer:management guidelines of the American Thyroid Association.Thyroid,2009,19:565-612. 被引量:1
  • 2Qi XP,Chen XL,Ma JM,et al.RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in China.Thyroid,2012,22:1257-1265. 被引量:1
  • 3QiXP,YingRB,MaJM,etal.Case report:Ap.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with Familial medullary thyroid carcinoma.Familial Cancer,2012,11:131-136. 被引量:1
  • 4Qi xP,Ma JM,Du ZF,et al.RET germline mutations identified by exome sequencing in a Chinese multiple endocrine neoplasia type 2A/Familial medullary thyroid carcinoma Family.PLoS One,2011,6:e20353 (1-9). 被引量:1
  • 5赵坚强,郭良,戚晓平,陈振光,王可敬,楼建林,余秀华,成军,金杭阳,李小龙,应荣彪,张成宁.RET原癌基因p.C618Y突变的家族性甲状腺髓样癌一家系的临床诊治分析[J].中华医学杂志,2013,93(6):440-444. 被引量:13
  • 6陈曦,蔡伟耀,宁光,何永刚,李宏为.多发性内分泌肿瘤2型的诊断和外科处理[J].中华普通外科杂志,2006,21(10):721-723. 被引量:4
  • 7戚晓平,王靖宇,金杭阳,等.多发性内分泌腺瘤病2A型的双侧肾上腺嗜铬细胞瘤一期切除术的安全性和疗效分析.中华泌尿外科杂志,2012,33:764-768. 被引量:1
  • 8Cheng SP,Saunders BD,Gauger PG,et al.Laparoscopic partial adrenalectomy for bilateral pheochromocytomas.Ann Surg Oncol,2008,15:2506-2508. 被引量:1
  • 9Pho LN,Smith FJ,Konecki D,et al.Paternal germ cell mosaicism in autosomal dominant pachyonychia congenita.Arch Dermato1,2011,147:1077-1080. 被引量:1
  • 10Elisei R,Romei C,Renzini G,et al.The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calciton in:18 years experience at one single center.J Clin Endocrinol Metab,2012,97:426-435. 被引量:1

二级参考文献19

  • 1Carling T.Multiple endocrine neoplasia syndrome:genetic basis for clinical management.Curr Opin Oncol,2005,17:7-12. 被引量:1
  • 2Toledo SPA,Cortina MA,Toledo RA,et al.DM.Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2.Clinics,2006,61:59-70. 被引量:1
  • 3Yip L,Cote GJ,Shapiro SE,et al.Multiple endocrine neoplasia type 2:evaluation of the genotype-phenotype relationship.Arch Surg,2003,138:409-416. 被引量:1
  • 4Brandi ML,Gagel RF,Angeli A,et al.Guidelines for diagnosis and therapy of MEN type 1 and type 2.J Clin Endocrinol Metab,2001,86:5658-5671. 被引量:1
  • 5Machens A,Dralle H.Multiple endocrine neoplasia type 2 and the RET protooncogene:from bedside to bench to bedside.Mol Cell Endocrinol,2006,247:34-40. 被引量:1
  • 6Carney JA.Familial multiple endocrine neoplasia:the first 100 years.Am J Surg Pathol,2005,29:254-274. 被引量:1
  • 7Kloos RT,Eng C,Evans DB. Medullary thyroid cancer:management guidelines of the American Thyroid Association[J].Thyroid:Official Journal of the American Thyroid Association,2009.565-612. 被引量:1
  • 8Qi XP,Chen XL,Ma JM. RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in China[J].Thyroid:Official Journal of the American Thyroid Association,2012.1257-1265. 被引量:1
  • 9Qi XP,Ma JM,Du ZF. RET germline mutations identified by exome sequencing in a Chinese multiple endocrine neoplasia type 2A/familial medullary thyroid carcinoma family[J].PLoS One,2011.e20353. 被引量:1
  • 10Qi XP,Ying RB,Ma JM. Case report:a p.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma[J].Familial Cancer,2012.131-136. 被引量:1

共引文献15

同被引文献20

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部